Healthy pregnancy hub

Isotretinoin (e.g. Accutane®)

Last Update: 29 Oct 2026

Medication
Welcome to our fact sheet on isotretinoin during pregnancy and lactation. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (January 2026).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on the one from MotherToBaby with United States information and has been reviewed by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is isotretinoin?

Isotretinoin is a prescription medication taken by mouth (orally) that has been used to treat severe cystic acne when other treatments have not worked. Isotretinoin is a type of retinoid made from vitamin A. Brand names include Accutane®, Absorica®, Amnesteem®, Claravis®, Epuris®, Clarus®, Myorisan®, Sotret®, and Zenatane®.

The product label for isotretinoin recommends not using this medication while pregnant or lactating because of the potential risk for a baby. If you are taking isotretinoin and find out you are pregnant, stop taking the medication and contact your healthcare professional immediately. If you are taking isotretinoin and want to get pregnant, talk with your healthcare professional.

Can I get a prescription for isotretinoin?

Isotretinoin can be prescribed under a special program called iPLEDGE® Risk Evaluation and Mitigation Strategy (REMS) in the United States and Pregnancy Prevention Program (PPP) in Canada. All requirements of the program must be followed to get prescriptions for isotretinoin.

Even if you are not sexually active or planning a pregnancy, if you use or want to use isotretinoin, it is recommended to talk to your healthcare professional. Using effective birth control methods is important because about 50% (1 out of 2) of pregnancies are unplanned.

2. What does research say about the safety during pregnancy?

I am taking isotretinoin, but I would like to stop taking it before getting pregnant. How long does the drug stay in my body?

The time it takes the body to metabolize (process) medication is not the same for everyone. In healthy non-pregnant adults, it takes up to 6 days, on average, for most of the isotretinoin to be gone from the body.

It is recommended to wait one month after stopping isotretinoin before trying to get pregnant.

I take isotretinoin. Can it make it harder for me to get pregnant? 

Some people taking isotretinoin have reported changes in their menstrual cycle (periods), but there are no reports that it makes it harder to get pregnant. However, it is not recommended to get pregnant while using isotretinoin.

I just found out I am pregnant. Should I stop taking isotretinoin?

Yes, it is recommended that you stop taking isotretinoin right away if you find out you are pregnant. As soon as possible, call the healthcare professional who prescribed the isotretinoin and the healthcare professional who will be taking care of you during pregnancy. Isotretinoin increases the chance of birth defects.

Does taking isotretinoin increase the chance of miscarriage? 

Miscarriage is common and can occur in any pregnancy for many different reasons. Taking isotretinoin can increase the chance of miscarriage. The chance of having a miscarriage can be as high as 40% when isotretinoin is used in early pregnancy.

Does taking isotretinoin increase the chance of birth defects? 

Birth defects can happen in any pregnancy for different reasons. Out of all babies born each year, about 3 out of 100 (3%) will have a birth defect. We look at research studies to try to understand if an exposure, like isotretinoin, might increase the chance of birth defects in a pregnancy.

Isotretinoin can cause birth defects in 35% or more of infants who are exposed during pregnancy. There is an increased chance of birth defects even if the medication has been taken for a short time. Most of the infants with birth defects will have small or absent ears and hearing and eyesight problems. Other issues that have been reported include heart defects, fluid around the brain, small jaw, small head, cleft palate (opening in the roof of the mouth), and/or missing thymus gland (a gland that makes hormones). Not every pregnancy exposed to isotretinoin will have birth defects. However, it is recommended to avoid any isotretinoin use in pregnancy. 

Does taking isotretinoin in pregnancy increase the chance of other pregnancy-related problems? 

The use of isotretinoin in pregnancy can increase the chance of preterm delivery (birth before week 37) and low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth).

Does taking isotretinoin in pregnancy affect future behavior or learning for the child? 

Children exposed to isotretinoin during pregnancy may have hearing or vision problems that can affect learning. They may also have behavioral problems or intellectual disability. These issues are not always seen at birth and may appear as the child grows.

What screenings or tests are available to see if my pregnancy has birth defects or other issues? 

Prenatal ultrasounds can screen for some birth defects and monitor the growth of the pregnancy. Talk with your healthcare professional about any prenatal screenings or testing that are available to you. There are no tests available during pregnancy that can tell how much effect there could be on future behavior or learning.

3. Lactating while taking isotretinoin

No information is available on the use of isotretinoin during breastfeeding, chestfeeding or pumping (lactating). Due to the lack of data, the product label recommends not using this medication while lactating. It is not known what effect, if any, exposure to isotretinoin through human milk can have on a nursing infant. Be sure to talk to your healthcare professional about all your lactating questions.

4. What about fathers and sperm donors?

If a male takes isotretinoin, could it affect fertility or increase the chance of birth defects? 

There have been a few reports of erectile dysfunction (trouble getting or keeping an erection) and ejaculatory problems (no semen released) in male taking isotretinoin. Changes in sperm morphology (size and shape) have also been reported. This could affect male’s fertility (ability to make healthy sperm). Studies have not been done in male to see if isotretinoin could increase the chance of birth defects. In general, exposures that fathers and sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Isotretinoin is used to treat severe acne, but it should not be used during pregnancy.
  • Taking isotretinoin during pregnancy can increase the risk of miscarriage, birth defects, and other pregnancy complications.
  • If you find out you are pregnant while taking isotretinoin, stop taking it and contact your healthcare team as soon as possible.
  • If you are planning a pregnancy, wait at least 1 month after stopping isotretinoin before trying to become pregnant.
  • Isotretinoin is not recommended while breastfeeding, because there is limited information about whether it passes into human milk or how it could affect a baby.
  • If you are taking or considering isotretinoin, talk with your healthcare team about contraception, pregnancy planning, and lactating.

References

Please click here for references.

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Nathalie Gagnon
Santé Québec - Outaouais
Judith Cottin
Sherif Eltonsy
University of Manitoba
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Our interactive tools

Stay inform with our monthly newsletter.

Subscribe here!

Explore our reading assistance tool.

Test them out today!

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University